Performance of claims-based frailty indices in Medicare Advantage and fee-for-service populations
- 18 September 2026
- journal article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (11)
Abstract
Background: Despite growing enrollment in Medicare Advantage (MA) plans, the performance of claims-based frailty algorithms, which were developed for Medicare fee-for-service (FFS), remains unclear in MA. Methods: We calculated the Kim claims-based frailty index (CFI), Veterans Affairs-Frailty Index (VA-FI), and Hospital Frailty Risk Score (HFRS) using the National Health and Aging Trends Study linked to Medicare FFS and MA data. We evaluated their performance against the comprehensive geriatric assessment-based frailty index (CGA-FI) and the frailty phenotype (FP) in Round 11 and Round 9. Results: Among 1527 FFS and 1457 MA beneficiaries in Round 11, frailty prevalence was 34.2% and 35.5%, respectively, by CGA-FI ≥0.25, and 13.3% and 16.2%, respectively, by FP. Across FFS and MA populations, the CFI, which prioritizes specificity and positive predictive value, classified 10%-12% of the overall population and 30%-36% of those with prior hospitalization as frail, whereas the VA-FI and HFRS, which emphasize sensitivity, classified 53%-71% of the overall population and 56%-87% of those with prior hospitalization as frail. Although claims-based frailty measures performed similarly across FFS and MA populations, their discriminatory ability was higher for CGA-FI ≥0.25 (C-statistics: CFI, 0.79-0.82; VA-FI, 0.77-0.82; HFRS, 0.63-0.77) than for FP (CFI, 0.71-0.77; VA-FI, 0.67-0.75; HFRS, 0.60-0.74). Performance was consistent by race and survey rounds, with modestly better discrimination in women than men. Conclusions: Claims-based frailty measures are scalable tools for contemporary FFS and MA populations. However, applying published thresholds led to differences in frailty prevalence and model performance. Thresholds should therefore be tailored to the intended.Keywords
Funding Information
- National Institute on Aging of the National Institutes of Health (R56AG084578)
- National Institute on Aging of the National Institutes of Health (K24AG073527)
This publication has 28 references indexed in Scilit:
- National Norms for Hospital Frailty Risk Score Among Hospitalized Adults in the USAJournal of General Internal Medicine, 2025
- Impact of Lookback Duration on the Performance of a Claims‐Based Frailty Proxy in Women With Stage I–III Breast CancerPharmacoepidemiology and Drug Safety, 2025
- Frailty in Older AdultsNew England Journal of Medicine, 2024
- Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care DataDrugs & Aging, 2024
- Automated Electronic Frailty Index–Identified Frailty Status and Associated Postsurgical Adverse EventsJAMA Network Open, 2023
- Updating International Classification of Diseases 9th Revision to 10th Revision of a Claims-Based Frailty IndexThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2020
- Predicting Mortality and Adverse Outcomes: Comparing the Frailty Index to General Prognostic IndicesJournal of General Internal Medicine, 2020
- Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational studyThe Lancet, 2018
- Development and validation of an electronic frailty index using routine primary care electronic health record dataAge and Ageing, 2016
- Frailty in Older Adults: Evidence for a PhenotypeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2001